Putnam Associates is a premier strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients, and the private equity / venture capital community. For 30 years, we have offered objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle.
Putnam recently sponsored Innovation Day at Harvard Medical School (HMS), the culmination of the HMS course on Healthcare, Innovation, and Commercialization. Putnam is proud to be a key supporter of the program and Partners Matt Riordan and Domenick Bertelli have served as guest lecturersread more
Eric Auger, Partner, was a recent speaker at the European Society of Gene & Cell Therapy Annual Congress held in collaboration with ISSCR and SFTCG, in Lausanne, Switzerland on October 16th-19th. The Congress brings together scientists, commercial leaders, business development professionals and investorsread more
Vault’s Consulting 50 ranks the best consulting firms in North America based on prestige, business outlook, and overall quality of life.Read More
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.